Evaluation of HEArt invoLvement in Patients With FABRY Disease (HEAL-FABRY)
Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A observational or N/A phase clinical study on Fabry Disease and Fabry Disease, Cardiac Variant, this trial is actively recruiting participants. The trial is conducted by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and has accumulated 12 data snapshots since 2001. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2022 — Jul 2024 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Recruiting
-
Jan 2020 — Mar 2020 [monthly]
Recruiting
-
Jun 2018 — Jan 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Competence Network Heart Failure
- St George's, University of London
- Wuerzburg University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .